Efficacy of dupilumab in moderate and severe atopic dermatitis

Efficacy of dupilumab in moderate and severe atopic dermatitis

Abstract Background Treatment responses may differ between patients with severe versus moderate atopic dermatitis (AD). Objectives To assess dupilumab response by baseline AD severity in adolescent and adult patients with moderate‐to‐severe AD. Methods We assessed dupilumab response by baseline AD s...

Full description

Bibliographic Details
Main Authors: Stephan Weidinger, Eric L. Simpson, Jonathan I. Silverberg, Jochen Schmitt, Yael A. Leshem, Norito Katoh, Zhen Chen, Haixin Zhang, Brad Shumel, Ashish Bansal, Jingdong Chao, Yufang Lu, Ana B. Rossi, Alvina Abramova
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:JEADV Clinical Practice
Subjects:
atopic dermatitis
disease assessments
disease severity
dupilumab
Online Access:https://doi.org/10.1002/jvc2.100

Internet

https://doi.org/10.1002/jvc2.100

Similar Items